Tapestry Announces Strategy to Focus ...

Tapestry Announces Strategy to Focus on TPI 287 Clinical Program

There are 1 comment on the Med Ad News story from Oct 26, 2007, titled Tapestry Announces Strategy to Focus on TPI 287 Clinical Program. In it, Med Ad News reports that:

“We continue to recruit patients for TPI 287's prostate and pancreatic cancer trials and we are moving forward with plans to initiate several other, previously announced studies”

Tapestry Pharmaceuticals, Inc. , announced today a plan to focus all of its resources on advancing TPI 287's on-going and previously announced clinical trials. via Med Ad News

Join the discussion below, or Read more at Med Ad News.

joseph m Cronan

Denver, CO

#1 Oct 26, 2007
It's sad state of affairs when promising drugs can not be developed because of some legalese. Is that what our society has progress too, better yet, digress or degraded too. If that is the case, let me die under the Mango Tree during a Tomumbo.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Uterine Cancer Discussions

Title Updated Last By Comments
News Gingrich's 1st divorce: still oft-told, varied ... (Nov '11) May '16 LBGT 27
fda approves viagra rival from drug maker vivus (Apr '16) Apr '16 Woods 1
News Americans: How health care law affected them (Nov '14) Nov '14 Not Cool 1
News NM attorney general: 'Right to die' ruling may ... (Jan '14) Jan '14 Lobo Viejo 14
News Official: 'Right to die' ruling may face appeal (Jan '14) Jan '14 Good 11
News Health: A fresh approach to cancer, plus keep a... (Nov '13) Nov '13 jjsalon 1
News Health risks fade when women quit estrogen (Apr '11) Oct '13 Miya Allen 3
More from around the web